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The CD8 ϩ T cells are key players in the immune response to intracellular infections and tumours. Recognition of any intracellular or viral protein by CD8 ϩ cytotoxic T lymphocytes requires an initial cytosolic proteolytic processing by proteasomes to peptide products, which are then translocated by transporters associated with antigen processing (TAP) into the endoplasmic reticulum (ER)
, where they assemble with major histocompatibility complex (MHC) class I molecules to be presented to the cell surface [1] .
Most peptides released from the proteasome into the cytosol are promptly degraded by cytosolic endopetidases and aminopeptidases to single amino acids before they can 'escape' by binding to the TAP and enter the ER. It has been calculated that only one peptide binds to an MHC class I molecule from 10
4 degraded proteins [2] . [3] . Previous Fig. 1B [7] . Previous studies in our laboratory and by others have demonstrated that the cytoplasmic/nuclear localization of E7 is lost by fusion to calreticulin which sequesters E7 to the ER [4] [5] [6] . As shown here again in Fig. 2 [4] [5] [6] [14, 15] . Another advantage of this strategy is to Fig. 3 
This explains the relatively subtle efficiency of antigen presentation by class I molecules. Coupled with this, cervical cancer cells (as well as a number of other malignant tumours) often show down regulation or, in a subset of cases, complete loss of MHC class I expression, most likely as a mechanism of immune escape
, the SP-E7-KDEL adenovirus expresses an 18 kD protein, as expected, in contrast to the 70 kD band expressed by the CRT-E7 adenovirus. To demonstrate that the SP-E7-KDEL fusion protein has been
Fig. 1 Generation of an adenovirus expressing SP-E7-KDEL. (A) Graphic representation of the gene constructs. Fusion of the HPV16 E7 protein and different signal sequences was made in silico and then gen synthesized. (B) Detection of the SP-E7-KDEL and CRT-E7 protein expression by Western blot. HEK293 cells were infected with the adenovirus expressing SP-E7-KDEL, CRT-E7, and LacZ at a multiplicity of infection (MOI) of 10. Twenty-four hours after infection cell-protein extracts were prepared and subjected to SDS-PAGE electrophoresis, and transferred to nitrocellulose membranes. These were incubated first with a monoclonal antibody against HPV16 E7 protein, then with the rabbit antimouse IgG-HRP second antibody, and developed with Super Signal West Pico stable peroxide solution.
Fig. 2 Distribution of the proteins SP-E7-KDEL and CRT-E7 to the ER. HEK293 cells infected at a MOI of 5 with an adenovirus expressing SP-E7-KDEL, Ad-CRT-E7 or
distributed to the ER, we did immunofluorescent staining of cells infected with the different adenoviruses using antibodies against E7 protein and calnexin (a well-characterized marker for the ER)
. All the mice had to be killed as well. In contrast, all the mice vaccinated with the adenovirus expressing SP-E7-KDEL or CRT-E7 eliminated the tumour. This similar protective effect demonstrates that the SP and KDEL signals are enough to enhance the antitumour immune response. Taken together, our results indicate that the adjuvant antitumour effect attributed to CRT [8-12] is mainly conferred by its SP and KDEL sequences, which allow antigens to enter and be maintained in the ER. The KDEL sequence is emerging as a significant antitumour immunity sequence. Recently, it was shown that dendritic cells loaded with exogenous peptides bearing the KDEL motif showed a more efficient antitumour activity than dendritic cells pulsed with peptides without KDEL [13]. Even though the mechanism of epitope generation in the ER is poorly understood, the KDEL sequence might result in a longer trafficking time through the ER, increasing the possibility of degradation and consequently, peptide generation and loading by the MHC-1 molecule. It will be worth determining the contribution of the SP itself to the adjuvant effect compared to the addition of both SP and KDEL sequences
